NCT05238038View on ClinicalTrials.gov

Electrical Impedance Tomography for the Assessment of Neurological Disease

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

June 28, 2019

Primary Completion Date

August 23, 2023

Study Completion Date

August 23, 2023

Conditions
Neuromuscular Disease PatientsCentral Neurological Disease Patients
Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Dartmouth College

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT05238038 - Electrical Impedance Tomography for the Assessment of Neurological Disease | Biotech Hunter | Biotech Hunter